title: [Lichen planus-like eruption. Case report].
abstract: Cutaneous adverse drug reactions are among the most common adverse drug reactions. Thise reactions to drugs can comprise a broad spectrum of clinical and histopathological features, with an important capacity to mimic numerous dermatological diseases, making the diagnose very difficult. We present the case of a patient, under immunomodulating treatment (TNFalpha antagonist and leflunomide), with a muco-cutaneous lichen planus-like eruption.
authors.affiliation: Disciplina de Dermatologie, Facultatea de Medicină, Universitatea de Medicină si Farmacie "Gr.T. Popa" Iaşi.
authors.forename: Laura
authors.initials: L
authors.lastname: Stătescu
authors.forename: Delia
authors.initials: D
authors.lastname: Ciobanu
authors.forename: Georgiana
authors.initials: G
authors.lastname: Mihăilă
authors.forename: C
authors.initials: C
authors.lastname: Stătescu
authors.forename: Laura Gheucă
authors.initials: LG
authors.lastname: Solovăstru
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000069285:Infliximab; D007555:Isoxazoles / Q000008:administration & dosage / Q000009:adverse effects*; D000077339:Leflunomide; D008010:Lichen Planus / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000069285:Infliximab; D000077339:Leflunomide